2013 Highlights

Business Revenue Mix

Annual Report Business Revenue Mix 2013

Click to enlarge

Geographic Revenue Mix

Annual Report Geographic Mix 2013

Click to enlarge

Our diversified portfolio includes medical technologies that address many of the world’s most pressing medical conditions.

* The data in this schedule has been intentionally rounded to the nearest whole percent, and therefore does not sum to 100%.

Sales in emerging markets grew from 10 percent of total sales in FY2012 to 11 percent in FY2013.


38%

Revenue From New Products

In FY2013, 38 percent of revenue came from products introduced in the past three years.

Annual Report 3 sec 2013

A Person's Life is Improved by a Medtronic Product or Therapy

In FY2013, we helped improve the lives of more than 9 million people around the worl.

36

Consecutive Years of
Increasing Our Cash Dividend

Medtronic is a member of the S&P 500 Dividend Aristocrat Index and raised its cash dividend by 8% in June 2013.



AR Highlights Earnings Graph

Click to enlarge

green bar Impact of excluding special charges. See page 9 for reconciliation of non-GAAP financial measures.

blue bar As reported

5-year CAGR** of 16.3% for diluted earnings per share.

5-year CAGR** of 6.5% for diluted earnings per share, excluding special charges. See page 9 for reconciliation of non-GAAP financial measures.

**Compound Annual Growth Rate
+53-week year